Warning: The NCBI web site requires JavaScript to function. more...
Mayo Clinic Hyperoxaluria Center, Rochester, Minnesota 55905, USA. milliner.dawn@mayo.edu
Despite advances in the enzymology, molecular genetics, and clinical knowledge of the primary hyperoxalurias, few treatments are available. Oxalobacter formigenes is a promising new therapy with potential to induce secretion of oxalate into the intestinal lumen, where it can be degraded by the bacteria.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on